Skin Patch for Children with Peanut Allergy Shows Benefit in Phase 3 Trial
Ann and Robert H. Lurie Children's Hospital of ChicagoAfter one year of wearing a peanut patch as immunotherapy for their peanut allergy, 35 percent of participating children (aged 4 to 11 years) were able to tolerate a significantly higher dose of peanuts before experiencing an allergic reaction, according to results from an international Phase 3 randomized clinical trial published in the Journal of the American Medical Association (JAMA).